The state Supreme Court waded through lengthy arguments Tuesday in a case in which the state of Pennsylvania has alleged two pharmaceutical companies inflated the price of their drugs at the government’s expense.
In the case of Commonwealth v. TAP Pharmaceutical Products, two pharmaceutical companies, Johnson & Johnson and Bristol-Myers Squibb, are appealing combined verdicts against them of roughly $80 million. The state alleged the companies inflated their drugs’ prices such that the government overpaid medical providers in prescription drug reimbursements.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
